News & Updates

Show Multimedia Only

Electroacupuncture outperforms transcutaneous electrical stimulation in severe constipation

22 Dec 2021

Administering acupuncture with a zap to patients with severe chronic constipation produces better outcomes than transcutaneous electrical stimulation, increasing the frequency of complete spontaneous bowel movements and improving quality of life, as shown in a study.

Electroacupuncture outperforms transcutaneous electrical stimulation in severe constipation

22 Dec 2021

Short-course vancomycin plus piperacillin-tazobactam tied to fewer AKI incidence

22 Dec 2021

Noncritically ill patients treated with a short course of vancomycin plus piperacillin-tazobactam (VPT) are less likely to experience acute kidney injury (AKI) than those who received an extended course, reports a study.

Short-course vancomycin plus piperacillin-tazobactam tied to fewer AKI incidence

22 Dec 2021

Mitapivat inches its way towards becoming first approved therapy for PK deficiency

22 Dec 2021 by

The investigational pyruvate kinase R (PKR) activator mitapivat continued to show benefit for individuals with PK deficiency (PKD) regardless of transfusion status, according to updated findings from the phase III ACTIVATE trials and the long-term extension (LTE) study.

Mitapivat inches its way towards becoming first approved therapy for PK deficiency

22 Dec 2021

Persistent smoking following surgery for early-stage lung cancer hurts survival

22 Dec 2021

For stage I non-small cell lung cancer (NSCLC) patients who underwent surgery, persistent smoking is detrimental to overall survival, a study has found.

Persistent smoking following surgery for early-stage lung cancer hurts survival

22 Dec 2021

Drinking water may reduce NAFLD prevalence in men

22 Dec 2021

Higher intake of plain water appears to suppress newly diagnosed nonalcoholic fatty liver disease (NAFLD) among men but not women, a recent study has found.

Drinking water may reduce NAFLD prevalence in men

22 Dec 2021

True North: Ozanimod benefits in ulcerative colitis evident in various populations

21 Dec 2021 by

A post hoc analysis of the phase III True North study showed that the benefits of ozanimod on clinical remission and response in patients with moderate-to-severe ulcerative colitis (UC) as seen in the global analysis were consistent in the analysis of the North American cohort.

True North: Ozanimod benefits in ulcerative colitis evident in various populations

21 Dec 2021

High-soy diets contribute to a long life

21 Dec 2021

Diets high in isoflavones appear to reduce the risk of all-cause mortality among middle-aged adults, reports a recent Japan study.

High-soy diets contribute to a long life

21 Dec 2021

Sleeve gastrectomy vs gastric bypass for weight loss: Which is safer?

21 Dec 2021 by

Sleeve gastrectomy was associated with a lower risk of mortality and complications over 5 years compared with gastric bypass, although the former intervention comes with an increased risk of surgical revision, reveals a recent study on patients undergoing bariatric surgery for weight loss.

Sleeve gastrectomy vs gastric bypass for weight loss: Which is safer?

21 Dec 2021

Hypotension prevents boosting of sacubitril/valsartan doses for Asians with ACHD-related HF

21 Dec 2021 by

The angiotensin receptor-neprilysin inhibitors (ARNI) sacubitril/valsartan does not appear to help manage heart failure (HF) in Asian patients with adult congenital heart disease (ACHD), with a small study from Singapore showing that the drug can only be tolerated at suboptimal doses and that hypotension prevents uptitration.

Hypotension prevents boosting of sacubitril/valsartan doses for Asians with ACHD-related HF

21 Dec 2021

Is continuous infusion labetalol haemodynamically safe for type B aortic dissections?

21 Dec 2021

Treatment with high-dose continuous intravenous labetalol (HD-CIVL) results in a nonstatistically significant higher incidence of haemodynamic instability compared to an esmolol combination (EC) regimen in patients with type B aortic dissections (TBADs), results of a study have shown.

Is continuous infusion labetalol haemodynamically safe for type B aortic dissections?

21 Dec 2021

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Electroacupuncture outperforms transcutaneous electrical stimulation in severe constipation

Electroacupuncture outperforms transcutaneous electrical stimulation in severe constipation

Short-course vancomycin plus piperacillin-tazobactam tied to fewer AKI incidence

Short-course vancomycin plus piperacillin-tazobactam tied to fewer AKI incidence

Mitapivat inches its way towards becoming first approved therapy for PK deficiency

Mitapivat inches its way towards becoming first approved therapy for PK deficiency

Persistent smoking following surgery for early-stage lung cancer hurts survival

Persistent smoking following surgery for early-stage lung cancer hurts survival

Drinking water may reduce NAFLD prevalence in men

Drinking water may reduce NAFLD prevalence in men

True North: Ozanimod benefits in ulcerative colitis evident in various populations

True North: Ozanimod benefits in ulcerative colitis evident in various populations

High-soy diets contribute to a long life

High-soy diets contribute to a long life

Sleeve gastrectomy vs gastric bypass for weight loss: Which is safer?

Sleeve gastrectomy vs gastric bypass for weight loss: Which is safer?

Hypotension prevents boosting of sacubitril/valsartan doses for Asians with ACHD-related HF

Hypotension prevents boosting of sacubitril/valsartan doses for Asians with ACHD-related HF

Is continuous infusion labetalol haemodynamically safe for type B aortic dissections?

Is continuous infusion labetalol haemodynamically safe for type B aortic dissections?